openPR Logo
Press release

Contrast Injector Systems Market Impact due to COVID 19 Along with Analysis of The Current Situation

08-06-2020 02:31 PM CET | Health & Medicine

Press release from: Allied Market Research

Contrast Injector Systems Market

Contrast Injector Systems Market

According to a new report published by Allied Market Research, Contrast Injector Systems Market by Product, Application and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the value of the global Contrast Injector Systems market was $954.62 million in 2016. Has been evaluated. , It is expected to grow by 8.1% annually from 2017 to 2023, reaching $946.2 million by 2023. The consumables segment accounted for about half of the global market share in 2016.

Click Here to Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/3977

The contrast injector system improves visibility of body structures such as body fluids, tissues, bones, veins, and arteries to diagnose diseases and disorders. The contrast agent injector system uses a contrast agent that enhances the body structure mentioned earlier. Visualization of various pathologies is achieved through imaging procedures such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography.

know more: https://www.alliedmarketresearch.com/contrast-injector-systems-market

Imaging procedures are on the rise due to an increase in various chronic conditions such as cancer, Alzheimer's and dementia. However, the high cost of contrast injector systems and the high risks associated with contrast injector systems, especially the use of media, hinder market growth. In addition, medical expenditures in developing countries and the emergence of complex diseases provide favorable opportunities for key market players.

The CT Injector Systems segment generated the highest revenue in 2016, accounting for about half of the total market share in 2016. This is due to the increased number of imaging procedures with CT scans and the increased sophistication of the CT injector system. However, the angiography system will grow at the fastest annual average growth rate of 8.7% during the forecast period. This is due to an increased number of heart diseases and an increased burden of initial heart attack diagnosis.

Among the end users, hospitals accounted for 32.9% of the total injector systems market in 2016 with the highest revenue, and it is expected to continue this trend throughout the forecast period. Moreover, the diagnostic center sector is expected to show a high growth rate of 8.9% as the trend of image processing in diagnostic centers increases. In addition, doctor's recommendations for CT and MRI scans in diagnostic centers further strengthen the global injector systems market.

Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/3977

Key Results of the Contrast Injector Systems Market:
• The Injector Systems segment accounted for about 2/5 of the total market in 2016 and is expected to grow at a high CAGR of 8.7% over the forecast period.
• Interventional Cardiology segment is the fastest growing application in the global market with a CAGR of 9.2% over the forecast period.
• The United States dominates the global contrast agent systems market and is expected to grow at a CAGR of 5.3% from 2017 to 2023.
• India was the fastest growing country in the Asia-Pacific contrast system market in 2016 with a CAGR of 11.7% and is expected to continue this trend over the forecast period.
• The hospital segment had the highest market share in 2016, growing at an annual average of 8.1% from 2017 to 2023.

The Asia Pacific region is expected to show the highest growth rate in the contrast system market during the forecast period, and this trend is expected to continue due to the high population density of countries such as India and China. In addition, a sharp increase in the elderly population and an increase in chronic diseases in developing countries are driving market growth.

Major players operating in the contrast agent system market have adopted product launches as one of their key development strategies, such as business expansion, product development and business acquisition. Leading companies included in the report include Bracco Imaging SpA, Bayer HealthCare, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd, Nemoto Kyorindo Co. Ltd., Sino Medical- Device, etc. Technology Co., Ltd. And Vivid Imaging. Other key players in value chain analysis include Imaxeon, Pty Ltd, Network Imaging Systems, IRadimed Corporation, Covidien, Agito Medical and Merit Medical Systems.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Contrast Injector Systems Market Impact due to COVID 19 Along with Analysis of The Current Situation here

News-ID: 2105556 • Views: 191

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Injector

Global Jet Injector Market Research and Forecast, 2018-2023
Global Jet Injector Market is Likely to Experience a Growth in Near Future | Market Opportunities and Forecast, 2018-2023 | Major Companies: AKRA DERMOJET, Antares Pharma, Inc., AstraZeneca PLC, Becton, Dickinson and Co., and Crossject According to OMR analysis, the global jet injector market is estimated to grow at a significant CAGR during the forecast period (2018-2023). Factors motivating the growth of this market are growing prevalence of chronic disease and
Contrast Injector Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Contrast Injector market. Contrast delivery is most effective and efficient using a medical device called a “power injector” that can be programmed to deliver specific amounts of contrast media. This “power injector” is the Contrast Injector. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/2443/global-contrast-injector-market Global Contrast Injector Market: Forecast by Type / Application / Region The global
Contrast Media Injector in Vascular Market Report 2018: Segmentation by Type (Si …
Global Contrast Media Injector in Vascular market research report provides company profile for Guerbet, Ulrich medical, APOLLO RT, MEDTRON, Anke High-Tech, Bayer, Bracco, Nemoto and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The
Contrast Injector Market Report 2018: Segmentation by Product (Single-head Contr …
Global Contrast Injector market research report provides company profile for Ulrich medical, MEDTRON, APOLLO RT, SinoMDT, Anke High-Tech, Bayer, Bracco, Nemoto, Guerbet and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also
Subcutaneous Injector Sales Market Report 2017
Subcutaneous Injector market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Browse the full report with a table of contents : https://www.reportsandmarkets.com/reports/global-subcutaneous-injector-sales-market-report-2017-1701051 Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Subcutaneous Injector for
Wearable Injector Market - Global Industry Analysis 2025
Drugs are mostly viscous and has various formulations (intravenous, intramuscular, and subcutaneous) that needs to be absorbed into digestive tract, which raise multiple drug delivery issue with traditional drug delivery system. Moreover, such issues not only raise costs but also decrease satisfaction and compliance of patients. Wearable injectors or bolus injectors are the new class for drug delivery device designed for subcutaneous delivery. It has capacity to hold the drug